Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health information: verify here.
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
|
Should Rofecoxib (Vioxx) Have Been Withdrawn Years Ago?
Henry I. Bussey, Pharm.D., FCCP, FAHA
November 2004
Review: Peter Jüni, Linda Nartey, Stephan Reichenbach, Rebekka Sterchi, Paul A Dieppe, Matthias Egger. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004; 364, 9447.*
Swedish investigators conducted a meta analysis of 18 randomized controlled trials and 11 observational reports to conclude that data were adequate to warrant withdrawal of rofecoxib as early as 2000. Further, these investigators point out that FDA data often provide more thorough information than published studies, and they suggest that companies should perform continuous monitoring and evaluations of their products.
*The full text of this article is available for free on The Lancet's website, but you may have to register to view it. Registration is free.
|
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
New Postings:
Click here to view full list of new postings
|